Ramipril and Osteitis - a phase IV clinical study of FDA data

Summary:

Osteitis is reported as a side effect among people who take Ramipril (ramipril), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Pain.

The phase IV clinical study analyzes which people have Osteitis when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Osteitis?

Osteitis (a general term for inflammation of bone) is found to be associated with 617 drugs and 456 conditions by eHealthMe. Check the latest studies of Osteitis.

On Aug, 08, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 69 people (0.05%) have Osteitis.

Among these 69 people:

How long have people been on Ramipril when they have Osteitis? *

What is the gender of people who have Osteitis when taking Ramipril? *

female: 55.93 %
male: 44.07 %

What is the age of people who have Osteitis when taking Ramipril? *

What are other drugs people take besides Ramipril? *

Zometa: 25 people, 36.23%
Acetaminophen: 20 people, 28.99%
Ibuprofen: 20 people, 28.99%
Clopidogrel Bisulfate: 20 people, 28.99%
Gabapentin: 19 people, 27.54%
Vancomycin: 19 people, 27.54%
Ativan: 18 people, 26.09%
Loratadine: 18 people, 26.09%
Miralax: 18 people, 26.09%
Prilosec: 18 people, 26.09%

What are other side effects people have besides Osteitis? *

Fatigue (feeling of tiredness): 38 people, 55.07%
Weakness: 38 people, 55.07%
Blood Calcium Decreased: 30 people, 43.48%
Loose Tooth: 30 people, 43.48%
Fall: 27 people, 39.13%
Fever: 26 people, 37.68%
Mobility Decreased (ability to move is reduced): 25 people, 36.23%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 25 people, 36.23%
Balance Disorder: 25 people, 36.23%
Dyspnea (difficult or laboured breathing): 25 people, 36.23%

What are the existing conditions these people have? *

Pain: 32 people, 46.38%
High Blood Cholesterol: 23 people, 33.33%
Joint Pain: 21 people, 30.43%
Type 2 Diabetes: 20 people, 28.99%
Multiple Myeloma (cancer of the plasma cells): 18 people, 26.09%
Fever: 18 people, 26.09%
Celiac Disease - Sprue (a disease of the small intestine): 16 people, 23.19%
Seasonal Allergy (allergic condition due to certain season): 16 people, 23.19%
Mood Swings (an extreme or rapid change in mood): 16 people, 23.19%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 23.19%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Osteitis?

- Check whether Osteitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Osteitis treatments and more:

Osteitis (5,726 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteitis:

Osteitis (617 drugs)

Browse all the conditions that are associated with Osteitis:

Osteitis (456 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.